Die thrombozytenkinetische Untersuchung Methodik und Anwendung

• LITERATUR

• 1 Julliard J, Maupin B, Chary R, Theilleux P, Loverdo A. Transfusion au lapin de leucocytes et de plaquettes due sang humain. C R Soc Biol. 1952; 146: 211-4.
• 2 Thakur M L. Radioisotop labelling of platelets: a historical perspective. Semin Thromb Haemostas 1983; 09: 79-85.
• 3 Aas K A, Gardner F H. Survival of blood platelets labeled with Chromium. J Clin Invest 1958; 37: 1257-68.
• 4 International Committee for Standardization in Hematology. Recommended methods for radioisotop platelet survival studies. Blood 1977; 50: 1137-44.
• 5 Mathias C J, Welch M J. Radiolabelling of platelets. Semin Nucl Med. 1984; 14: 118-27.
• 6 Thakur M L, Welch M J, Joist J H, Coleman R E. Indium-111 labelled platelets: studies on preparation and evaluation of in vivo and in vitro functions. Thromb Res. 1976; 09: 345-57.
• 7 Joist J H, Baker R K, Welch M J. Methologic and basic aspects of Indium-111 platelets. Semin Thromb Haemostas 1983; 09: 86-99.
• 8 Baker J R J, Butler K D, Eakins M N, Pay G F, White A M. Subcellular localization of ¹¹¹In in human and rabbit platelets. Blood 1982; 59: 351-9.
• 9 Reenen van O R, Lotter M G, Minnaar T C, Heynsdu A P, Badenhorst P N, Pieters H. Radiation dose from human platelets labelled with Indium-111. Brit J Radiol. 1980; 53: 790-5.
• 10 Scheffel U, Tsan M F, Mitchell T G, Camargo E E, Braine H, Ezekowitz M D, Nickoloff E L, Hill-Zobel R, Murphy E, McIntyre P A. Human platelets labelled with In-111-8-hydroxyquinoline: Kinetics, distribution and estimates of radiation dose. J Nucl Med. 1982; 23: 149-56.
• 11 Hawker R J, Hawker L M, Wilkinson A R. Indium (¹¹¹In)-labelled human platelets: Optimal method. Clin Sci. 1980; 58: 243-8.
• 12 Mathias C J, Heaton W A, Welch M J, Douglas P G, Kelly J D. Comparison of ¹¹¹In-oxine and of ¹¹¹In-acetylacetone for the labeling of cells: In-vivo and in-vitro biological testing. Int J Appl Radiol Isot. 1981; 32: 651-6.
• 13 Thakur M L, Walsh L, Malech H L, Gottschalk A. Indium-Ill-labeled human platelets: Improved method, efficacy and evaluation. J Nucl Med. 1981; 22: 381-5.
• 14 Heynsdu A P, Badenhorst P N, Pieters H, Lötter M G, Minnaar P C, Duyvene de Wit L J, van Reenen O R, Retief F P. Preparation of a viable population of Indium-Ill- labelled human blood platelets. Thromb Haemostas 1979; 42: 1473-82.
• 15 Wessels P A, Heynsdu A P, Pieters H, Lötter M G, Badenhorst P N. An improved method for the quantification of the in vivo kinetics of a representative population of ¹¹¹In-labelled human platelets. Eur J Nucl Med. 1985; 10: 522-7.
• 16 Aster R H. Pooling of platelets in the spleen: Role in the pathogenesis of “hypersplenic” thrombocytopenia. J Clin Invest. 1966; 45: 645-57.
• 17 Heynsdu A P, Lotter M G, Badenhorst P, van Reenen O R, Pieters H, Minnaar P C, Retief F P. Kinetics, distribution and sites of destruction of Ill-labelled human platelets. Br J Haematol. 1980; 44: 269-80.
• 18 Peters A M, Lavender P J. Platelet kinetics with Indium-111-platelets: Comparison with Chromium-51 platelets. Semin Thromb Hemostas. 1983; 09: 100-14.
• 19 Peters A M, Saverymuttu S H, Wonke B, Lewis M, Lavender J P. The interpretation of platelet kinetic studies for the identification of sites of abnormal platelet destruction. Br J Haematol. 1984; 57: 637-649.
• 20 Dornhorst A C. The interpretation of red cell survival curves. Blood. 1961; 06: 1284-92.
• 21 Murphy E A, Francis M E. The estimate of blood platelet survival. II Multiple hit model. Thromb Diath Haemorrh. 1971; 25: 53-80.
• 22 Heaton W A, Davis H H, Welch M J, Mathias C J, Joist J H, Sherman L A, Siegel B A. Indium-111. A new radionuclide label for studying human platelet kinetics. Br J Haematol. 1979; 42: 613-22.
• 23 Tsan M F. Kinetics and distribution of platelets in man. Am J Haematol. 1984; 17: 97-104.
• 24 Harker L A, Finch C A. Thrombokinetics in man. J Clin Invest 1969; 48: 963-74.
• 25 Najean Y, Ardaillou N. The sequestration site of platelets in idiopathic thrombocytopenic purpura: its correlation with results of splenectomy. Br J Haematol. 1971; 21: 153-64.
• 26 Kiefel V, Becker T, Mueller-Eckhardt G, Grebe S, Mueller-Eckhardt C. Platelet survival determined with ⁵¹Cr versus ¹¹¹In. Klin Wschr. 1985; 63: 84-9.
• 27 Aster R H. Studies on the fate of platelets in rats and in man. Blood 1969; 34: 117-28.
• 28 Aster R H, Jandl J H. Platelet sequestration in man. I Methods. J Clin Invest 1964; 43: 843-55.
• 29 Robertson J S, Dewanjee M K, Brown M L, Fuster V, Chesebro J H. Distribution and dosimetry of ¹¹¹In-labeled platelets. Radiology 1981; 140: 169-76.
• 30 Klonizakis I, Peters A M, Fitzpatrick M L, Kensett M J, Lavender J P, Lewis S M. Radionuclide distribution following injection of 111-indium-labelled platelets. Br J Haematol 1980; 46: 595-602.
• 31 Klonizakis I, Peters A M, Fitzpatrick M L, Kensett M J, Lavender J P, Lewis S M. Spleen function and platelet kinetics. J Clin Pathol. 1981; 34: 377-80.
• 32 Myers T J, Kim B K, Steiner M, Baldini M G. Selection of donor platelets for alloimmunized patients using a platelet-associated IgG assay. Blood 1981; 58: 444-50.
• 33 Peters A M, Saverymuttu S H, Bell R N, Lavender J P. Kinetics of shortlived Indium-111 radiolabelled platelets. Scand J Haematol. 1985; 34: 137-45.
• 34 Branehög I, Kutti J, Weinfeld A. Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP). Br J Haematol. 1974; 27: 127-43.
• 35 Schmidt K G, Rasmussen J W. Kinetics and distribution in vivo of ¹¹¹In-labelled autologous platelets in idiopathic thrombocytopenic purpura. Scand J Haematol. 1985; 34: 47-56.
• 36 Kernoff L M, Blake K C H, Shakelton D. Influence of the amount of platelet-bound IgG on platelet survival and site of sequestration in autoimmune thrombocytopenia. Blood 1980; 55: 730-3.
• 37 Mueller-Eckhardt C, Mueller-Eckhardt G, Kayser W, Voss R M, Wegner J, Kiienzlen E. Platelet associated IgG, platelet survival, and platelet sequestration in thrombocytopenic states. Br J Haematol. 1982; 52: 49-58.
• 38 Panzer S, Niessner H, Homan R, Dudczak R. Classes of platelet-associated immunoglobulins (PAIg) and platelet-associated C3c (PAC3c) in relation to ¹¹¹In-platelet-survival and site of sequestration. Blut. 1985; 51 205 (Abstract).
• 39 Davis H H, Varki A, Heaton W A, Siegel B A. Detection of accessory spleens with indium-Ill-labeled autologous platelets. Am J Hematol. 1980; 08: 81-6.
• 40 Panzer S, Lechner K, Neumann E, Meryn S, Haubenstock A. ¹¹¹Indium labelled platelet kinetic studies and platelet-associated IgG in hairy cell leukemia. Cancer. (im Druck).
• 41 Harker L A, Slichter S J. Platelet and fibrinogen consumption in man. N Engl J Med. 1972; 287: 99-103.
• 42 Fuster V, Chesebro J H, Elveback L R. Platelet survival and the development of coronary artery disease in the young adult: Effects of cigarette smoking, strong family history and medical therapy. Circulation 1980; 63: 546-51.
• 43 Ritchie J L, Harker L A. Platelet and fibrinogen survival in coronary atherosclerosis. Response to medical and surgical therapy. Am J Cardiol. 1977; 39: 595-8.
• 44 Steele P, Battock D, Genton E. Effect of Clofibrate and Sufinpyrazone on platelet survival time in coronary artery disease. Circulation 1985; 52: 473-6.
• 45 Steele P, Rainwater J, Vogel R, Genton E. Platelet suppressant therapy in patients with coronary artery disease. JAMA. 1978; 240: 228-31.
• 46 Tindall H, Paton C, McNicol G P. Aspirin, dipyridamole and platelet survival in patients with diabetes mellitus. Clinical Science 1982; 63: 205-9.
• 47 Ross R, Harker L. Hyperlipidemia and atherosklerosis. Science 1976; 193: 1094-100.
• 48 Hay C R M, Durber A P, Saynor R. Effect of fish oil on platelet kinetics in patients with ischaemic heart disease. Lancet 1982; I: 1269-72.
• 49 Dawanjee M K. Cardial and vascular imaging with labeled platelets and leukocytes. Semin Nucl Med. 1984; 14: 154-86.
• 50 Powers W J, Siegel B A. Thrombus imaging with Indium-111 platelets. Semin Thromb Haemostasis 1983; 09: 115-31.
• 51 Hanson R, Harker L A. Effects of platelet-modifying drugs on arterial thromboembolism in bamboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. J Clin Invest 1985; 74: 1591-9.
• 52 Ritchie J L, Stratton J R, Thiele B, Hamilton G W, Warrick L N, Huang T W, Harker L A. Indium-111 platelet imaging for detection of platelet deposition in abdominal aneurysms and prosthetic arterial grafts. Am J Cardiol. 1981; 47: 882-9.
• 53 Powers W J, Siegel B A, Davis H H, Mathias C J, Clark H B, Welch M J. Indium-111 platelet scintigraphy in cerebrovascular disease. Neurology 1982; 32: 938-43.
• 54 Goldman M, Norcott H C, Hawker R J, Drolc Z, McCollum C N. Platelet accumulation on mature Dacron grafts in man. Br J Surg. 1982; 69: 539-40.
• 55 Goldman M, Norcott H C, Hawker R J, Hail C, Drolc Z, McCollum C N. Femoro-popliteal bypass graft - an isotop technique allowing in vivo comparison of thrombogenicity. Br J Surg. 1982; 69: 380-2.
• 56 Wu K K, Chen Y-C, Fordham E, Ts’ao C-H, Raydu G, Matayoshi D. Differential effects of two doses of aspirin on plateletvessel wall interaction in vivo. J Clin Invest 1981; 68: 382-7.
• 57 Ezekowitz M D, Wilson D A, Smith E O, Burow R D, Harrison jr L H, Parker D E, Elkins R C, Peyton M, Taylor F B. Comparison of indium-111 platelet scintigraphy and two-dimensional echocardiography in the diagnosis of left ventricular thrombi. N Engl J Med. 1982; 306: 1509-13.
• 58 Moser K M, Fedullo P F. Imaging of venous thromboemboli with labeled platelets. Semin Nucl Med. 1984; 14: 188-207.
• 59 Sinzinger H, Leitner C, Höfer R. Continuous monitoring of human kidney transplants by autologous labelled platelets. Nucl Geneeskund Bull. 1982; 04 (Suppl): 44-6.